- Morning AI
- Posts
- The Key to Faster Cures and Precision Medicine
The Key to Faster Cures and Precision Medicine
Good Morning,
Google DeepMind has just unveiled AlphaProteo, a groundbreaking AI that’s poised to revolutionize drug discovery and cancer research. This cutting-edge system designs custom proteins that bind with specific molecular targets, achieving a precision 3 to 300 times greater than current methods.
TODAY IN MORNING AI
Tesla’s Global Road Trip
Microsoft will unveil the latest advancements in AI
Dell’s AI Boom
AlphaProteo is revolutionizing drug discovery and precision medicine.
AI Fun Fact
and more…
Read Time: 5.3 minutes
AI HEADLINES
TOP AI STORIES
- OpenAI’s Pricing Party: Rumor has it OpenAI’s considering super high-end subscriptions for their top-tier AI models, like Strawberry and Orion, costing up to $2,000 a month!
- Tesla’s Global Road Trip: Tesla’s revving up to roll out its AI-powered Full Self-Driving feature in China and Europe by early 2025, just waiting for the green light from regulators.
- Dell’s AI Boom: Dell Technologies is on a sales spree with AI servers, and CEO Michael Dell isn’t worried about any slowdown in AI spending—he’s riding high!
- World’s AI Treaty: The US, EU, and UK have signed the world’s first international AI treaty, making sure AI plays nice with human rights and accountability.
- Microsoft’s AI Reveal: Mark your calendars for September 16! Microsoft’s dropping the next big thing in AI with their “Microsoft 365 Copilot: Wave 2” event.
AI DEVELOPMET
Breakthrough AI AlphaProteo: The Key to Faster Cures and Precision Medicine
Source: Proventa International
Google DeepMind has just unveiled AlphaProteo, a groundbreaking AI that’s poised to revolutionize drug discovery and cancer research. This cutting-edge system designs custom proteins that bind with specific molecular targets, achieving a precision 3 to 300 times greater than current methods.
AlphaProteo has already demonstrated its prowess by creating effective binders for 7 out of 8 diverse targets, including critical cancer-related proteins. Remarkably, independent tests suggest that some of its designs could inhibit SARS-CoV-2 (Covid) from infecting cells, potentially reducing years of lab work to mere days or weeks.
The implications are huge: AlphaProteo could drastically enhance our ability to combat viruses, tackle cancer, and develop targeted treatments with fewer side effects, dramatically accelerating drug discovery and potentially saving billions in research and development costs while bringing life-saving therapies to patients faster than ever.
TOOLBOX
SOME USEFUL AI TOOLS
You.com: AI-powered search agent offering personalized recommendations.
Altera PlayLabs: Create and interact with AI agents in an online playground.
melty: Open-source AI code editor designed to enhance developer productivity.
timeMaster: Efficiently manage your time with privacy-centric tracking features.
LanguageTool: Multilingual grammar and spell checker for precise writing.
PROMPT OF THE DAY
A USEFUL/PRODUCTIVE PROMPT
Please provide a list of essential reads or resources for advancing in leadership.
By using this prompt, you'll receive a curated list of resources designed to enhance your leadership skills.
AI FUN FACT
DID YOU KNOW?
The AI behind Google's DeepDream was initially created to help improve image recognition? It became famous for generating surreal, dream-like images by enhancing patterns it saw in pictures—think of it as AI's version of a psychedelic art project!
AI DESIGNS
CRAFTED BY AI
Prompt: A closeup underwater photograph of a beautiful woman with long flowing blond hair flowing languidly in the water. Shafts of sunlight slant in from above. --ar 1:1 --style raw --v [5.2, 6.0, 6.1]
It’s a wrap!
Thank you for taking the time to read this. Your engagement and support mean the world to us. We hope you found this newsletter both informative and inspiring. Stay tuned for more exciting news and stories in our next edition.
P.S. Don't forget to share this newsletter with your friends & colleagues for real-time updates and exclusive content. We love hearing from you, so feel free to share your thoughts and feedback!